Aegerion Pharma Inc (AEGR) 1.47 $AEGR Aegerion (AEGR):

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Aegerion Pharma Inc (AEGR) 1.47 $AEGR

Aegerion (AEGR): What Awaits for the Stock in Q2 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 9:03AM CDT
Aegerion (AEGR) is expected to report second-quarter 2016 results on Aug 3.
IPXL: 31.15 (-0.27), IRWD: 13.94 (-0.19), AEGR: 1.47 (+0.03), EXEL: 9.27 (+0.09)

Aegerion, QLT Ink Merger Deal to Form Novelion Therapeutics
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 11:23PM CDT
Aegerion Pharmaceuticals, Inc. (AEGR) announced that it has entered into a definitive merger agreement with QLT Inc. (QLTI).
ABT: 45.29 (+0.54), JNJ: 125.40 (+0.17), QLTI: 1.37 (unch), AEGR: 1.47 (+0.03)

Aegerion Pharmaceuticals and QLT Inc. Agree to Strategic Merger
GlobeNewswire - Wed Jun 15, 6:00AM CDT
--Strategic Merger Creates Well-Capitalized, Global Biopharmaceutical Organization with Diverse Portfolio of Two Commercialized Rare Disease Programs and a Phase 3 Ready Ultra-Orphan Development Program Addressing Significant Unmet Medical Need--
QLTI: 1.37 (unch), QLT.TO: 1.80 (unch), AEGR: 1.47 (+0.03)

Pre-market Insights on Biotechnology Stocks -- BioMarin Pharma, Alexion Pharma, Aegerion Pharma, and Acorda Therapeutics
PR Newswire - Thu Jun 09, 7:40AM CDT
On Wednesday, June 08, 2016, the NASDAQ Composite ended the trading session at 4,974.64, up 0.26%; the Dow Jones Industrial Average advanced 0.37% to finish at 18,005.05; and the S&P 500 closed at 2,119.12, up 0.33%. The gains were broad based as all the sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Aegerion Pharmaceuticals Inc. (NASDAQ: AEGR), and Acorda Therapeutics Inc. (NASDAQ: ACOR). Learn more about these stocks by accessing their free trade alerts at:
BMRN: 100.25 (+0.83), ALXN: 133.50 (+4.90), AEGR: 1.47 (+0.03), ACOR: 25.13 (-0.15)

Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
GlobeNewswire - Tue Jun 07, 3:45PM CDT
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, today announced that on June 1, 2016, Aegerion granted stock options to purchase an aggregate of 10,958 shares of common stock to six new employees under the inducement stock option program described below. Each stock option has an exercise price per share equal to $1.93, the closing price of Aegerion's common stock on the grant date; vests 25% on the first anniversary of the date of grant with the remaining 75% to vest in monthly installments over the three years thereafter; has a ten year term; and is subject to the terms and conditions of Aegerion's Inducement Award Stock Option Plan, and the terms and conditions of a stock option agreement covering the grant.
AEGR: 1.47 (+0.03)

Robbins Arroyo LLP Is Investigating the Officers and Directors of Aegerion Pharmaceuticals, Inc. (AEGR) on Behalf of Shareholders
BusinessWire - Thu May 19, 6:01PM CDT
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Aegerion Pharmaceuticals, Inc. (NASDAQGS: AEGR) violated their legal obligations to the company and its shareholders in connection with alleged violations of drug marketing requirements, securities laws, and the Health Insurance Portability and Accountability Act ("HIPAA". Aegerion, a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States.
AEGR: 1.47 (+0.03)

Aegerion (AEGR) Misses Q1 Earnings Estimates, Cuts View
Zacks Equity Research - Zacks Investment Research - Tue May 17, 9:06AM CDT
Aegerion Pharmaceuticals, Inc. (AEGR) reported a loss of $1.85 per share in the first quarter of 2016, much wider than both the Zacks Consensus Estimate of a loss of 54 cents.
ABT: 45.29 (+0.54), JNJ: 125.40 (+0.17), PFE: 37.31 (+0.42), AEGR: 1.47 (+0.03)

Aegerion reports 1Q loss
Automated Insights - Mon May 16, 3:19PM CDT
CAMBRIDGE, Mass. (AP) _ Aegerion Pharmaceuticals Inc. (AEGR) on Monday reported a loss of $65.6 million in its first quarter.
AEGR: 1.47 (+0.03)

Aegerion Pharmaceuticals Announces First Quarter 2016 Financial Results
GlobeNewswire - Mon May 16, 3:05PM CDT
-- Company records $35.7 million in total net product sales
AEGR: 1.47 (+0.03)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation into Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aegerion, Inc.
BusinessWire - Fri May 13, 2:41PM CDT
Levi & Korsinsky announces it has commenced an investigation of Aegerion, Inc. ("Aegerion" or the "Company" (NASDAQ:AEGR) concerning possible breaches of fiduciary duty.
AEGR: 1.47 (+0.03)

Faruqi & Faruqi, LLP is Investigating Aegerion Pharmaceuticals, Inc. (AEGR) on Behalf of its Shareholders
PR Newswire - Fri May 13, 12:52PM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at Aegerion Pharmaceuticals, Inc. ("Aegerion" or the "Company" (NASDAQ:AEGR).
AEGR: 1.47 (+0.03)

Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Hold Aegerion Pharmaceuticals, Inc. Stock
PR Newswire - Fri May 13, 11:43AM CDT
Bernstein Liebhard LLP is investigating whether the Board of Directors of Aegerion Pharmaceuticals, Inc. ("Aegerion" or the "Company" (NASDAQ: AEGR) breached their fiduciary duties to shareholders by violating the Food, Drug, and Cosmetic Act (the "Act" in connection with the Company's sales activities and disclosures related to its lead drug, JUXTAPID.
AEGR: 1.47 (+0.03)

Aegerion Enters into Settlement Agreement with DoJ and SEC
Zacks Equity Research - Zacks Investment Research - Fri May 13, 8:36AM CDT
Aegerion Pharmaceuticals, Inc. (AEGR) announced that it has reached preliminary agreements with the U.S. DoJ and staff of the SEC.
ABT: 45.29 (+0.54), AEGR: 1.47 (+0.03), ACOR: 25.13 (-0.15), SNY: 42.49 (-0.14)

Aegerion Pharmaceuticals Announces Preliminary Agreements in Principle With DOJ and SEC Related to Ongoing Investigations
GlobeNewswire - Thu May 12, 7:15AM CDT
Aegerion Pharmaceuticals, Inc. ("Aegerion" or the "Company" (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced today that it has reached preliminary agreements in principle with the Department of Justice ( "DOJ" and the staff of the Securities and Exchange Commission ("SEC" regarding a settlement of the ongoing investigations by these agencies into the Company's sales activities and disclosures related to JUXTAPID(R) (lomitapide) capsules ("JUXTAPID".
AEGR: 1.47 (+0.03)

Aegerion Pharmaceuticals to Announce First Quarter 2016 Financial Results on Monday, May 16
GlobeNewswire - Wed May 11, 7:05AM CDT
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced that the Company will host a conference call and live audio webcast at 5:00 p.m. EDT on Monday, May 16, 2016, to provide a business update and to discuss its first quarter 2016 financial and operating results.
AEGR: 1.47 (+0.03)

SurModics (SRDX) Beats Q2 Earnings & Revenues Estimates
Zacks Equity Research - Zacks Investment Research - Tue May 03, 12:27PM CDT
SurModics' (SRDX) second-quarter of fiscal 2016 adjusted earnings of 20 cents per share beat the Zacks Consensus Estimate of 8 cents.
SRDX: 27.06 (-0.37), GILD: 80.46 (+0.99), ANIP: 61.06 (+0.46), AEGR: 1.47 (+0.03)

Mallinckrodt (MNK) Tops Q2 Earnings and Sales, Ups View
Zacks Equity Research - Zacks Investment Research - Tue May 03, 9:49AM CDT
Mallinckrodt (MNK) reported adjusted earnings of $2.01 per share in the second quarter of fiscal 2016 (ended Mar 25, 2016), beating the Zacks Consensus Estimate of $1.72.
MNK: 67.37 (+0.03), GILD: 80.46 (+0.99), MDCO: 39.03 (-0.08), AEGR: 1.47 (+0.03)

Merrimack (MACK) Posts Narrower-than-Expected Loss in Q1
Zacks Equity Research - Zacks Investment Research - Tue May 03, 9:33AM CDT
Merrimack Pharmaceuticals, Inc. (MACK) reported a loss of 33 cents per share in the first quarter of 2016, narrower than both the Zacks Consensus Estimate of 39 cents and the prior-quarter loss of 41 cents.
MACK: 5.82 (+0.02), GILD: 80.46 (+0.99), AEGR: 1.47 (+0.03), BXLT: 46.02 (-0.18)

Mylan Beats on Q1 Earnings, Revenues Lag, 2016 View Intact
Zacks Equity Research - Zacks Investment Research - Tue May 03, 8:30AM CDT
Mylan's (MYL) first-quarter 2016 earnings (excluding special items) of 76 cents per share beat the Zacks Consensus Estimate by a penny.
GILD: 80.46 (+0.99), ANIP: 61.06 (+0.46), MYL: 46.74 (-0.05), AEGR: 1.47 (+0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Misunderstood Brands Bets Small Cans Can Scale Growth

Updated Category News Views 177

A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...

Continue Reading
Innoviz's 1-for-20 Split Is a Listing Lifeline Test

Updated Category News Views 79

A twenty-share pile of INVZ is about to become one share, and nobody should confuse that paperwork with a turnaround. Innoviz plans to enact a 1-for-20 reverse split at 11:59 p.m. Eastern on Friday, December 4, with split-adjusted trading expected when Nasdaq opens on December 7. This is a blunt instrument aimed at one immediate problem: getting the quoted share price...

Continue Reading
DigiKey’s Arduino Webinar Puts Edge AI Hardware to Work

Updated Category News Views 68

A Small Board With a Big Practical Question Edge AI is finally getting dragged out of the slide deck and onto the workbench, which is where it ought to prove itself. DigiKey plans to host a free 60-minute webinar on Dec. 2, 2026, at 10 a.m. CST covering Arduino’s new VENTUNO Q edge AI computer. The session promises a hardware tour, an Arduino App Lab walkthrough, and a...

Continue Reading
OCEG Faces China's Demographic Test After 40 Years

Updated Category News Views 61

A school group that once opened 35 kindergartens in a year is admitting the old playbook has run its course. That is the real message behind Oriental Cambridge Education Group's 40th-anniversary talk, not the balloons and ceremonial language. OCEG operates more than 170 institutions across 39 Chinese cities, and its chairman, Yu Yue, says the next chapter will be judged...

Continue Reading
Ampace Fire Test Gives Data Centers Useful Evidence

Updated Category News Views 150

Battery cabinets are becoming the awkward guest in the AI data-center boom: absolutely necessary, expensive to install, and nobody wants to discover their failure behavior during a real emergency. Ampace’s newly presented PU100 large-scale fire-test results deserve attention for that reason. This is not a magic safety stamp, and the company says the findings apply only...

Continue Reading
Century's Florence Model Openings Put Arizona in Focus

Updated Category News Views 72

Six furnished houses in Florence may sound like a modest ribbon-cutting, but homebuilding is a business of small field signals before the quarterly numbers ever show up. Century Communities is scheduled to host a November grand opening for six model homes spanning two new communities in Florence, Arizona. For investors tracking NYSE:CCS, that is not a thesis by itself. It...

Continue Reading
Roland DG's Brand Refresh Earns Three B2B Awards in 2026

Updated Category News Views 57

Three trophies for a printer-maker’s marketing overhaul will not move mountains by themselves, but they do tell us Roland DG has stopped treating its brand like an afterthought. The company’s global Make Your Mark refresh picked up two Silver awards and one Bronze at the 2026 Drum B2B Awards in Miami. For a business selling industrial-grade tools into crowded,...

Continue Reading
AWK Adds Fayette Water System With $9M Upgrade Plan

Updated Category News Views 121

Small water systems do not usually collapse in one dramatic heap; they get worn down by scattered pipes, compliance demands, thin staffing and bills nobody wants to raise. That is the backdrop for Pennsylvania American Water’s completed $32.8 million purchase of the Indian Creek Valley Water Authority system. For American Water shareholders, this is the familiar...

Continue Reading
A Hybrid Book Bets on Muscles, Myth, and Machines

Updated Category News Views 32

Few publishing pitches ask readers to carry a barbell into Tartarus, but A R Quigley is plainly not chasing the middle of the bookstore. Doctrina Machina Learning Machine, released by Palmetto Publishing in November 2026, welds together a strength-training guide and an underground military science-fiction war story. That is an odd little contraption, no use pretending...

Continue Reading
Visual Cipher Bench Exposes AI Agents' Hidden Rule Gap

Updated Category News Views 130

Forty little black-and-white puzzles just threw a bucket of cold water on the autonomous-agent sales pitch. Einsia AI’s Navers Lab says its new Visual Cipher Bench found that the best result among eight frontier models was only 26.7%, with no tested configuration clearing 30%. That is not a minor blemish. It is a reminder that a model can sound clever, use tools, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Private Aviation's Trust Crisis Amid Industry Consolidation

Updated Category News Views 182

The landscape of private aviation is transforming under a weighty cloak of financial strain and operational challenges. With recent disruptions in commercial flights grabbing headlines, travelers are sharpening their focus on safety rather than brand allure. As operators in this space grapple with tightening regulations and fluctuating customer expectations, the spotlight...

Continue Reading
CPSC Warns Against Hazards of EnHomee Tall Dressers

Updated Category News Views 329

Warning Issued on EnHomee Tall Dressers The U.S. Consumer Product Safety Commission (CPSC) has issued an urgent warning, advising consumers to stop using the EnHomee tall fabric dressers immediately. These dressers pose significant risks due to their instability if not securely anchored to the wall, potentially leading to serious injuries or even fatalities from tip-over...

Continue Reading
UK Retailers Adopt Automation Amid Rising Costs Challenges

Updated Category News Views 288

UK Retailers Turn to Automation for Savings Big retailers in the UK are ramping up their push for efficiency as they navigate rising operational costs. Key players such as Tesco (OTC: TSCDY), Sainsbury (LON: SBRY), Marks & Spencer, and Next (LON: NXT) are exploring automation and other cost-saving measures to maintain competitive pricing for their customers. Challenges...

Continue Reading
CenterPoint Energy Announces Increased Quarterly Dividend Payout

Updated Category News Views 154

CenterPoint Energy Announces New Dividend Rate CenterPoint Energy, Inc. has declared a regular quarterly cash dividend of $0.2200 per share for its common stock. This announcement was made by the Board of Directors and continues to showcase the company's commitment to shareholders. The dividend will be payable to stockholders of record on a specified date. This adjustment...

Continue Reading
Cincinnati Financial Reports Impressive Q3 Growth Figures

Updated Category News Views 73

Cincinnati Financial's Q3 Performance Overview Cincinnati Financial Corporation (NASDAQ: CINF) has recently unveiled its third-quarter results for the year, revealing a compelling narrative of growth despite some challenges in earnings. The insurer managed to outperform revenue expectations, posting impressive results that caught the eye of analysts and investors alike....

Continue Reading